These sources consist of legitimate science or are evidence-based through the use of credible scientific sourcing. Legitimate science follows the scientific method, is unbiased, and does not use emotional words. These sources also respect the consensus of experts in the given scientific field and strive to publish peer-reviewed science. Some sources in this category may have a slight political bias but adhere to scientific principles. See all Pro-Science sources.
- Overall, we rate BioSpace a pro-science website that is High in factual reporting.
Bias Rating: PRO-SCIENCE
Factual Reporting: HIGH
Country: USA (45/180 Press Freedom)
Media Type: Website
Traffic/Popularity: High Traffic
MBFC Credibility Rating: HIGH CREDIBILITY
Founded in 1985 and based in Iowa, BioSpace publishes news on life sciences and biology. According to their about page, “BioSpace.com is the most comprehensive Life Science industry news and information source. We cover news across the biotech, pharmaceutical, and medical device industries. We also provide industry-specific career news, advice, and resources to support and inspire ongoing professional development.”
Funded by / Ownership
Biospace Inc. owns biospace.com. They generate revenue through event sponsorships and advertising.
Analysis / Bias
The website primarily focuses on industry-related news covering mergers, the pharmaceutical industry, and reports on clinical trials. Articles and headlines use moderately loaded language such as this Four Biotechs Rake in Over $350 Million for Rare Diseases, Cancers and More. When it comes to sourcing information, they use credible sources such as Business Wire and PR Newswire. They also publish advances in research and development such as this Eagle Pharmaceuticals Announces TREAKISYM (bendamustine) Ready-to-Dilute (“RTD”) Formulation. In general, Biospace promotes pro-science news with minimal political bias, though they tend to favor the pharmaceutical industry.
Failed Fact Checks
- None to date
Overall, we rate BioSpace a pro-science website that is High in factual reporting. (D. Van Zandt 4/30/2021)